School of Medicine
Showing 211-220 of 374 Results
-
Andrew Chin, DO, MS, MPH
Clinical Assistant Professor, Medicine
BioDr. Andrew Chin is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine and works as a hospitalist at Stanford Health Care. He attended medical school at Midwestern University in Glendale, Arizona and completed his internal medicine residency at University Hospitals of Cleveland in Cleveland, Ohio.
-
Albert Sean Chiou, MD, MBA
Clinical Professor, Dermatology
Current Research and Scholarly InterestsI am a clinical researcher interested in evaluating promising new diagnostic paradigms and treatments for serious or poorly treated, chronic skin conditions. My research currently includes:
Therapeutics:
- Treatments for atopic dermatitis and other inflammatory skin conditions
- Treatments for itch from epidermolysis bullosa
- Treatments for chronic wounds for patients with recessive dystrophic epidermolysis bullosa (In collaboration with Dr. Jean Tang and Dr. Peter Marinkovich)
Diagnostics:
- Artificial intelligence approaches for melanoma and skin cancer early detection
- Imaging mass spectrometry for skin cancer margin analysis and diagnosis
I collaborate with other faculty within the Stanford Skin Innovation and Interventional Research Group (SIIRG) to conduct investigator initiated and sponsored clinical trials seeking to improve care for important dermatologic diseases
Please learn more about our work at: https://siirg.stanford.edu/ -
Gheorghe Chistol
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsResearch in my laboratory is aimed at understanding how eukaryotes replicate their DNA despite numerous challenges (collectively known as replication stress), and more generally – how eukaryotic cells safeguard genome integrity. Specifically, we are investigating: (i) mechanisms that regulate the activity of the replicative helicase during replication stress, (ii) mechanisms that control the inheritance of epigenetic information during replication, and (iii) mechanisms of ubiquitin-mediated regulation of genome maintenance. We utilize single-molecule microscopy to directly image fluorescently-labeled replication factors and track them in real time in Xenopus egg extracts. I developed this system as a postdoctoral fellow, and used it to monitor how the eukaryotic replicative helicase copes with DNA damage. We plan to further extend the capabilities of this platform to directly visualize other essential replication factors, nucleosomes, and regulatory post-translational modifications like ubiquitin chains. By elucidating molecular mechanisms responsible for maintaining genome stability, we aim to better understand the link between genome instability and cancer, and how these mechanisms can be harnessed to improve disease treatment.
-
Ritu Chitkara
Clinical Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsSimulation based research, Neonatal Resuscitation research
-
Usha Chitkara
Professor of Obstetrics and Gynecology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsRh disease, other red call isoimmunization, e.g. Kell, etc.
I.T.P. and alloimmune thrombocytopenia
Multiple pregnancy (twins, triplets, etc.) and associated problems and procedures
Ultrasound referrals -- complicated and routine
Procedures --cordocentesis, intrauterine transfusion; selective termination or reduction in multiple pregnancy. -
Bill Chiu
Associate Professor of Surgery (Pediatric Surgery)
BioDr. Chiu obtained his B.S. degree in Biological Sciences and graduated with Honors from Stanford University. After graduating, he received his Medical Degree at Northwestern University Feinberg School of Medicine, where he remained for his internship and General Surgery residency training. Dr. Chiu completed his Pediatric Surgery training at The Children’s Hospital of Philadelphia. He is an Associate Professor at Stanford University School of Medicine where he has an active research program studying innovative approaches to treat patients with neuroblastoma.